4 Geographic Atrophy Clinical Trials in Las Vegas, NV (2026)

Q: How do I join a clinical trial in Las Vegas?

Browse available studies, click one that interests you, and complete the free eligibility form. A study coordinator at the Las Vegas research site will contact you.

Recruiting Geographic Atrophy Studies in Las Vegas

NCT05683418Recruiting

A Study to Evaluate the Safety and Tolerability of TOS-358 in Women With HR+ HER2- Breast Cancer

The goal of this clinical trial is to evaluate the safety and efficacy of TOS-358 in women with HR+ HER2- metastatic breast cancer whose tumors have a mutation in PIK3CA and who meet all other study e...

Las Vegas, NV241 participantsTotus Medicines

View Study Details

NCT06930625Recruiting

A Study to Assess the Efficacy and Safety of Debio 4126 in Participants With Acromegaly Previously Treated With Somatostatin Analogs

The primary purpose of this study is to assess the effect of Debio 4126 in the maintenance of the levels of insulin-like growth factor 1 (IGF-1) ≤1x upper limit of normal (ULN) in the double-blind per...

Las Vegas, NVPHASE3119 participantsDebiopharm International SA

View Study Details

NCT07037420Recruiting

ALXN2420 Versus Placebo in Combination With Somatostatin Analogs in Participants With Acromegaly

The primary objective of this study is to evaluate the efficacy of 15-week treatment with ALXN2420 versus placebo for decreasing insulin-like growth factor IGF-1 levels, when administered in combinati...

Las Vegas, NVPHASE260 participantsAlexion Pharmaceuticals, Inc.

View Study Details

NCT06797518Recruiting

Study to Evaluate the Impact of Iptacopan on Top of SOC on Biopsy Changes in Kidneys of Adult Patients With IgAN

A study to investigate the impact of iptacopan treatment on the underlying immunopathology in patients with IgAN by assessing changes in key clinical and molecular markers from baseline to 9 months. T...

Las Vegas, NV20 participantsNovartis Pharmaceuticals

View Study Details

About Geographic Atrophy Clinical Trials in Las Vegas

Geographic atrophy is the advanced form of dry age-related macular degeneration, involving progressive loss of retinal cells. It leads to enlarging blind spots in central vision. Recently approved complement inhibitor therapies can slow progression.

There are currently 4 geographic atrophy clinical trials recruiting participants in Las Vegas, NV. These studies are seeking a combined 440 participants. Research is being sponsored by Totus Medicines, Debiopharm International SA, Alexion Pharmaceuticals, Inc. and 1 other organizations. Clinical trial participation is free and participants receive study-related medical care at no cost.

Geographic Atrophy Clinical Trials in Las Vegas — FAQ

Are there geographic atrophy clinical trials in Las Vegas?

Yes, there are 4 geographic atrophy clinical trials currently recruiting in Las Vegas, NV. Browse the studies on this page to find one that fits.

How do I join a clinical trial in Las Vegas?

Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the Las Vegas research site will contact you about next steps.

Are clinical trials in Las Vegas free?

Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many Las Vegas studies also compensate for your time and travel.

What geographic atrophy treatments are being tested?

The 4 active trials in Las Vegas are testing new therapies including novel drugs, biologics, and treatment approaches for geographic atrophy.

Data updated July 14, 2026 from ClinicalTrials.gov